Company intelligence / Profile preview

The Resilience Project

La Jolla, California, USAtheresilienceproject.com.au ↗

Ownership: Private
Development stage: Other

Overview

National Resilience is an active commercial-stage technology-focused biomanufacturing company providing end-to-end solutions for complex medicines including biologics, vaccines, cell and gene therapies. It operates as a CDMO with advanced cGMP facilities in North America and supports both small/mid-sized biotech companies and large pharma clients. The company has formed key partnerships to expand domestic manufacturing capabilities for critical pharmaceutical ingredients[2][3][7].

Modalities: BiologicsVaccinesGene therapyCell therapyNucleic acids
Industry: Contract Manufacturing Organization

Partnerships

Parvus Therapeutics – development/manufacturing of PVT401 for IBDAralez Bio – partnership on amino acid production platform

Beyond the preview

Go deeper on The Resilience Project.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Resilience Project.

Explore the full profile